AAAAAA
Results:
1-17
|
Results: 17
Authors:
Hartung, G
Hofheinz, RD
Wein, A
Riedel, C
Rost, A
Fritze, D
Kreuser, ED
Drees, M
Kuhnel, J
Hehlmann, R
Queisser, W
Citation: G. Hartung et al., Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer, ONKOLOGIE, 24(5), 2001, pp. 457-462
Authors:
Dencausse, Y
Sturm, J
Hartung, G
Diezler, P
Edler, L
Bambach, M
Wojatschek, C
Lindemann, H
Queisser, W
Citation: Y. Dencausse et al., Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: Evaluation of feasibility, ONKOLOGIE, 24(5), 2001, pp. 476-480
Authors:
Queisser, W
Citation: W. Queisser, Practice for preventive oncology, ONKOLOGIE, 24(5), 2001, pp. 505-512
Authors:
Samel, S
Hofheinz, R
Hundt, A
Sturm, J
Knoll, MR
Wenz, F
Queisser, W
Post, S
Citation: S. Samel et al., Neoadjuvant radio-chemotherapy of adeno-carcinoma of the oesophagogastric junction, ONKOLOGIE, 24(3), 2001, pp. 278-282
Authors:
Queisser, W
Citation: W. Queisser, Gerd A. Nagel and the Journal ONKOLOGIE, ONKOLOGIE, 24, 2001, pp. V-VI
Authors:
Ritzrau, W
Graf, C
Scheltz, A
Queisser, W
Citation: W. Ritzrau et al., Bentho-pelagic coupling and carbon dynamics in the northern North Atlantic, NORTHERN NORTH ATLANTIC: A CHANGING ENVIRONMENT, 2001, pp. 207-224
Authors:
Hartung, G
Hofheinz, R
Buchheidt, D
Rost, A
Brecht, A
Forche, K
Schroder, M
Wojatschek, C
Fritze, D
Hehlmann, R
Queisser, W
Citation: G. Hartung et al., Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer: Results of a phase II trial, ONKOLOGIE, 23(5), 2000, pp. 444-447
Authors:
Franz, A
Bewersdorf, H
Hartung, G
Dencausse, Y
Queisser, W
Citation: A. Franz et al., Exacerbation of Wegener's granulomatosis following single administration of monoclonal antibody 17-1A (Panorex (R)) during adjuvant immunotherapy of colon cancer, ONKOLOGIE, 23(5), 2000, pp. 472-474
Authors:
Queisser, W
Hartung, G
Kopp-Schneider, A
Diezler, P
Hagmuller, E
Baur, A
Weniger, J
Wojatschek, C
Janssen, N
Hossfeld, D
Lindemann, H
Schnabel, T
Edler, L
Citation: W. Queisser et al., Adjuvant radio-chemotherapy with 5-fluorouracil and leucovorin in stage IIand III rectal cancer: 12 months vs. 6 months of therapy - A study of the Association for Medical Oncology of the German Cancer Society, ONKOLOGIE, 23(4), 2000, pp. 334-339
Authors:
Hartung, G
Heeger, S
Bertsch, T
Frei, E
Wunder, A
Kranzle, M
Stehle, G
Weigand, M
Schrenk, HH
Sinn, H
Queisser, W
Citation: G. Hartung et al., Adaptation and clinical evaluation of a homogenous enzyme multiplied immunoassay technique (EMIT) for drug monitoring of a methotrexate-albumin conjugate (MTX-HSA) in humans, ONKOLOGIE, 23(4), 2000, pp. 352-357
Authors:
Queisser, W
Citation: W. Queisser, 30 years of medical oncology, ONKOLOGIE, 23(4), 2000, pp. 386-390
Authors:
Queisser, W
Scheithauer, W
Citation: W. Queisser et W. Scheithauer, Milestones of clinical oncology in the 20th century, ONKOLOGIE, 23(1), 2000, pp. 8-8
Authors:
Hartung, G
Stehle, G
Sinn, H
Wunder, A
Schrenk, HH
Heeger, S
Kranzle, M
Edler, L
Frei, E
Fiebig, HH
Heene, DL
Maier-Borst, W
Queisser, W
Citation: G. Hartung et al., Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients, CLIN CANC R, 5(4), 1999, pp. 753-759
Authors:
Queisser, W
Scheithauer, W
Citation: W. Queisser et W. Scheithauer, Towards the next millennium, ONKOLOGIE, 22(1), 1999, pp. 8-8
Authors:
Springer, B
Friedrichs, M
Graf, G
Nittikowski, J
Queisser, W
Citation: B. Springer et al., A high-precision current measurement system for laboratory flume systems: a case study around a circular cylinder, MAR ECOL-PR, 183, 1999, pp. 305-310
Authors:
Hehlmann, R
Hochhaus, A
Kolb, HJ
Hasford, J
Gratwohl, A
Heimpel, H
Siegert, W
Finke, J
Ehninger, G
Holler, E
Berger, U
Pfirrmann, M
Muth, A
Zander, A
Fauser, AA
Heyll, A
Nerl, C
Hossfeld, DK
Loffler, H
Pralle, H
Queisser, W
Tobler, A
Citation: R. Hehlmann et al., Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure, BLOOD, 94(11), 1999, pp. 3668-3677
Authors:
Queisser, W
Manegold, K
Citation: W. Queisser et K. Manegold, Is there a standard for adjuvant treatment of Dukes B and C rectal carcinoma?, ONKOLOGIE, 21(6), 1998, pp. 518-520
Risultati:
1-17
|